{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:09:12Z","timestamp":1787238552742,"version":"build-2736575974"},"reference-count":38,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.2169\/internalmedicine.1067-22","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T17:10:17Z","timestamp":1672161017000},"page":"2483-2491","source":"Crossref","is-referenced-by-count":7,"title":["Factors and Reasons for Non-vaccination among Patients with Systemic Lupus Erythematosus: A Single-centre, Cross-sectional Study"],"prefix":"10.2169","volume":"62","author":[{"given":"Hirofumi","family":"Miyake","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Tenri Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Minoda Sada","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Tenri Hospital, Japan"},{"name":"Department of Infection Control, Graduate School of Medicine, Osaka University, Japan"},{"name":"Department of Transformative Protection to Infectious Disease, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Tenri Hospital, Japan"},{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Tsugihashi","sequence":"additional","affiliation":[{"name":"Medical Home Care Centre, Tenri Hospital Shirakawa Branch, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Tenri Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78: 736-745, 2019.","DOI":"10.1136\/annrheumdis-2019-215089"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22: 1286-1294, 2013.","DOI":"10.1177\/0961203313493032"},{"key":"3","unstructured":"3. Cervera R, Khamashta MA, Font J, et al.; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82: 299-308, 2003."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fei Y, Shi X, Gan F, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 33: 57-63, 2014.","DOI":"10.1007\/s10067-013-2383-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fors Nieves CE, Izmirly PM. Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep 18: 21, 2016.","DOI":"10.1007\/s11926-016-0571-2"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Furer V, Rondaan C, Heijstek M, et al. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open 5: e001041, 2019.","DOI":"10.1136\/rmdopen-2019-001041"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Schurder J, Goulenok T, Jouenne R, et al. Pneumococcal infection in patients with systemic lupus erythematosus. Joint Bone Spine 85: 333-336, 2018.","DOI":"10.1016\/j.jbspin.2017.05.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Luijten RK, Cuppen BV, Bijlsma JW, Derksen RH. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections. Lupus 23: 1512-1516, 2014.","DOI":"10.1177\/0961203314543918"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Guthridge JM, Cogman A, Merrill JT, et al. Herpes zoster vaccination in SLE: a pilot study of immunogenicity. J Rheumatol 40: 1875-1880, 2013.","DOI":"10.3899\/jrheum.130170"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mok CC. Herpes zoster vaccination in systemic lupus erythematosus: the current status. Hum Vaccin Immunother 15: 45-48, 2019.","DOI":"10.1080\/21645515.2018.1514228"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79: 39-52, 2020.","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pug\u00e8s M, Biscay P, Barnetche T, et al. Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis. Rheumatology (Oxford) 55: 1664-1672, 2016.","DOI":"10.1093\/rheumatology\/kew211"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liao Z, Tang H, Xu X, Liang Y, Xiong Y, Ni J. Immunogenicity and safety of influenza vaccination in systemic lupus erythematosus patients compared with healthy controls: a meta-analysis. PLoS One 11: e0147856, 2016.","DOI":"10.1371\/journal.pone.0147856"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 6: 300-305, 2007.","DOI":"10.1016\/j.autrev.2006.09.012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chang CC, Chang YS, Chen WS, Chen YH, Chen JH. Effects of annual influenza vaccination on morbidity and mortality in patients with systemic lupus erythematosus: a nationwide cohort study. Sci Rep 6: 37817, 2016.","DOI":"10.1038\/srep37817"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Adawi M, Bragazzi NL, McGonagle D, et al. Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: an evidence-informed and PRISMA compliant systematic review and meta-analysis. Autoimmun Rev 18: 73-92, 2019.","DOI":"10.1016\/j.autrev.2018.08.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chehab G, Richter JG, Brinks R, Fischer-Betz R, Winkler-Rohlfing B, Schneider M. Vaccination coverage in systemic lupus erythematosus - a cross-sectional analysis of the German long-term study (LuLa cohort). Rheumatology (Oxford) 57: 1439-1447, 2018.","DOI":"10.1093\/rheumatology\/key120"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yazdany J, Tonner C, Trupin L, et al. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther 12: R84, 2010.","DOI":"10.1186\/ar3011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Krasselt M, Baerwald C, Seifert O. Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic. Z Rheumatol 77: 727-734, 2018.","DOI":"10.1007\/s00393-017-0410-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lawson EF, Trupin L, Yelin EH, Yazdany J. Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus. Semin Arthritis Rheum 44: 666-671, 2015.","DOI":"10.1016\/j.semarthrit.2015.01.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O. Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 67: 1047, 2008.","DOI":"10.1136\/ard.2007.081703"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Assala M, Groh M, Blanche P, et al. Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and\/or immunosuppressive therapies for systemic autoimmune diseases: a cross-sectional study. Joint Bone Spine 84: 365-366, 2017.","DOI":"10.1016\/j.jbspin.2016.03.013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hmamouchi I, Winthrop K, Launay O, Dougados M. Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. Vaccine 33: 1446-1452, 2015.","DOI":"10.1016\/j.vaccine.2015.01.065"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Shimazawa R, Ikeda M. The vaccine gap between Japan and the UK. Health Policy 107: 312-317, 2012.","DOI":"10.1016\/j.healthpol.2012.05.012"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147: 573-577, 2007.","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.","DOI":"10.1002\/art.1780251101"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.","DOI":"10.1002\/art.1780400928"},{"key":"28","unstructured":"28. Aringer M, Costenbader K, Daikh D, et al. 2019 European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71: 1400-1412, 2019."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. O'Brien CP. The CAGE questionnaire for detection of alcoholism: a remarkably useful but simple tool. JAMA 300: 2054-2056, 2008.","DOI":"10.1001\/jama.2008.570"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Dub\u00e9 E, Gagnon D, Ouakki M, et al.; Canadian Immunization Research Network. Understanding vaccine hesitancy in Canada: results of a consultation study by the Canadian Immunization Research Network. PLoS One 11: e0156118, 2016.","DOI":"10.1371\/journal.pone.0156118"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Pugliese-Garcia M, Heyerdahl LW, Mwamba C, et al. Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia. Vaccine 36: 5617-5624, 2018.","DOI":"10.1016\/j.vaccine.2018.07.042"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Castleberry A, Nolen A. Thematic analysis of qualitative research data: is it as easy as it sounds? Curr Pharm Teach Learn 10: 807-815, 2018.","DOI":"10.1016\/j.cptl.2018.03.019"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Petri M, Kim MY, Kalunian KC, et al.; OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353: 2550-2558, 2005.","DOI":"10.1056\/NEJMoa051135"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 68: 1069-1075, 2019.","DOI":"10.15585\/mmwr.mm6846a5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med 142: 260-273, 2005.","DOI":"10.7326\/0003-4819-142-4-200502150-00008"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Fischer L, Gerstel PF, Poncet A, et al. Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases - a longitudinal study. Arthritis Res Ther 17: 151, 2015.","DOI":"10.1186\/s13075-015-0663-9"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mok CC, Chan KH, Ho LY, Fung YF, Fung WF, Woo PCY. Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial. Ann Rheum Dis 78: 1663-1668, 2019.","DOI":"10.1136\/annrheumdis-2019-215925"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12: 36-44, 2012.","DOI":"10.1016\/S1473-3099(11)70295-X"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/17\/62_1067-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:28:40Z","timestamp":1715560120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/17\/62_1067-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":38,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1067-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"article-number":"1067-22"}}